BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,842,854 | +36.1% | 542,776 | +35.3% | 0.02% | +42.9% |
Q2 2023 | $2,824,511 | -2.6% | 401,209 | +15.4% | 0.01% | -12.5% |
Q1 2023 | $2,899,076 | +808.5% | 347,611 | +1150.6% | 0.02% | +700.0% |
Q4 2022 | $319,098 | -78.8% | 27,796 | -69.9% | 0.00% | -71.4% |
Q1 2022 | $1,503,000 | +96.7% | 92,430 | +91.2% | 0.01% | +75.0% |
Q2 2021 | $764,000 | -37.6% | 48,352 | -92.1% | 0.00% | -63.6% |
Q1 2020 | $1,224,000 | +100.0% | 611,934 | +244.8% | 0.01% | +175.0% |
Q4 2019 | $612,000 | +684.6% | 177,482 | +992.0% | 0.00% | – |
Q1 2018 | $78,000 | -57.6% | 16,253 | -56.7% | 0.00% | -100.0% |
Q4 2017 | $184,000 | -28.1% | 37,528 | -23.2% | 0.00% | -50.0% |
Q3 2017 | $256,000 | -32.3% | 48,855 | -63.3% | 0.00% | -33.3% |
Q2 2016 | $378,000 | -33.7% | 133,005 | -34.0% | 0.00% | -25.0% |
Q1 2016 | $570,000 | -73.3% | 201,573 | -2.4% | 0.00% | -77.8% |
Q4 2015 | $2,132,000 | -21.5% | 206,573 | -13.3% | 0.02% | -18.2% |
Q3 2015 | $2,716,000 | +101.0% | 238,273 | +163.3% | 0.02% | +83.3% |
Q2 2015 | $1,351,000 | -6.8% | 90,498 | -43.6% | 0.01% | 0.0% |
Q1 2015 | $1,450,000 | -44.0% | 160,598 | -24.6% | 0.01% | -42.9% |
Q4 2014 | $2,591,000 | +56.4% | 213,098 | +25.8% | 0.02% | +61.5% |
Q3 2014 | $1,657,000 | -18.3% | 169,398 | +13.4% | 0.01% | -7.1% |
Q2 2014 | $2,029,000 | -67.1% | 149,398 | -71.7% | 0.01% | -68.9% |
Q1 2014 | $6,167,000 | – | 528,098 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |